Related Experiment Video
Updated: Aug 26, 2026

A Luciferase-fluorescent Reporter Influenza Virus for Live Imaging and Quantification of Viral Infection
Published on: August 14, 2019
Every nose counts: a new influenza vaccine for all healthy schoolchildren?
Manjusha J Gaglani1, Gayla B Herschler
1Section of Pediatric Infectious Diseases, Scott & White Memorial Hospital/Clinic, Scott, Sherwood and Brindley Foundation, Texas A&M University System Health Science Center College of Medicine, Temple, Texas 76508, USA.
Insights
Vaccinating healthy schoolchildren against influenza can prevent widespread epidemics. This approach aims to limit virus transmission, benefiting both children and the wider community by reducing winter outbreaks.
Area of Science:
- * Public Health and Epidemiology
- * Vaccinology and Immunology
Background:
- * Influenza is a contagious respiratory illness that spreads easily in school settings.
- * School-aged children are significant vectors for influenza transmission to families and communities.
- * Uncontrolled winter epidemics pose a substantial public health burden.
Purpose of the Study:
- * To evaluate the potential public health impact of vaccinating schoolchildren against influenza.
- * To determine if protecting healthy children can limit influenza spread and reduce societal impact.
Main Methods:
- * Review of influenza transmission dynamics in school settings.
- * Assessment of an investigational live-attenuated, cold-adapted, trivalent influenza vaccine.
- * Analysis of vaccine efficacy in healthy children and adults aged 5–49 years.
Main Results:
- * The investigational vaccine was approved by the FDA for licensure.
- * The vaccine targets prevention of influenza in healthy individuals aged 5–49.
- * Schoolchildren represent a key demographic for influenza transmission control.
Conclusions:
- * Protecting schoolchildren against influenza is a viable strategy to curb community-wide spread.
- * Widespread vaccination in schools can mitigate winter influenza epidemics.
- * This intervention offers significant societal benefits by reducing disease burden.
Abstract:
Influenza is a vaccine-preventable disease. However, influenza virus spreads among children in schools and daycare centers, then to families and communities, causing uncontrolled epidemics every winter. The United States Food and Drug Administration evaluated and approved an investigational live-attenuated, cold-adapted, trivalent influenza vaccine for licensure, for prevention of influenza in healthy children and healthy adults, 5 through 49 years of age. Could protection of healthy schoolchildren against influenza limit its spread and benefit society?
More Related Videos
06:34An Optimized Hemagglutination Inhibition (HI) Assay to Quantify Influenza-specific Antibody Titers
Published on: December 1, 2017
12:09Measuring Influenza Neutralizing Antibody Responses to A(H3N2) Viruses in Human Sera by Microneutralization Assays Using MDCK-SIAT1 Cells
Published on: November 22, 2017
Related Concept Videos
Vaccinations
Influenza
Respiratory Syncytial Virus Disease
Infectious Diseases and Their Occurrence
Vaccines
Smallpox